[COMMENTARY] A Patent Pool: What Are the Risks?

Posted on by

Today and tomorrow, December 14-15, the executive board of UNITAID will vote on whether to move forward with plans for a patent pool. A patent pool is a consortium of companies that share a license to a particular product or technology. In this case, manufacturers of AIDS drugs would give a limited number of generic manufacturers the right to produce those drugs. Competition between the generic manufacturers would then drive down the price of drugs in countries where many people currently cannot afford AIDS drugs.

Controversy has roiled over the patent pool idea since some have suggested that middle-income countries should be excluded. A lot of those countries are in Asia; see this letter from APN+, the network of people living with HIV in Asia, which clearly lays out the issues.

(more…)

[REPORT] Give Everyone the Right to Affordable Medicines

Posted on by

By Shiwei Ye

The high cost of medicines essential for the prevention, treatment and cure of many diseases makes them inaccessible to millions of patients who need them. The World Health Organization estimates this to include a third of the world’s population. In parts of Asia, the percentage may be even higher.

One of the key factors making medicines unaffordable is the current intellectual property right (IPR) regime and its prominent place in many free trade agreements. There is a dire need to reform the current international trade framework in order to provide correct and adequate incentives that can lead to need-based medical innovations and that can ensure that public health is prioritized over commercial interests.

 

(more…)